Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection

Molecular Pharmaceutics

Volumn 3, Issue 6, 2006, Pages 654-664

  Anatelli, Florencia ^a,b   Mroz, Pawel ^a,b   Liu, Qingde ^a,b   Yang, Changming ^a,b   Castano, Ana P ^a,b   Swietlik, Emilia ^a,c   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Flow cytometry; Intratumoral injection; Photosensitizer targeting; Scavenger receptors; Tumor associated macrophages

Indexed keywords

ALBUMIN CONJUGATE; CHLORIN E6; HETEROCYCLIC COMPOUND; MALEYLALBUMIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; FLOW CYTOMETRY; FLUORESCENCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR CELL; TUMOR LOCALIZATION;

ANIMALS; FLOW CYTOMETRY; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENOUS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SARCOMA; SERUM ALBUMIN, BOVINE; SUCCINIMIDES; TISSUE DISTRIBUTION; TRANSPLANTATION, ISOGENEIC; TUMOR CELLS, CULTURED;

EID: 33846124005     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060024y     Document Type: Article

References (44)

1. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1 (4), 279-293.
2. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Mechanisms in photodynamic therapy: part two -cellular signalling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2004, 2 (1), 1-23.
3. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3 (5), 380-387.
4. Hamblin, M. R.; Newman, E. L. On the mechanism of the tumour-localising effect in photodynamic therapy. J. Photochem. Photobiol. B 1994, 23 (1), 3-8.
5. Konan, Y. N.; Gurny, R.; Allemann, E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 2002, 66 (2), 89-106.
6. Sharman, W. M.; van Lier, J. E.; Allen, C. M. Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Delivery Rev. 2004, 56 (1), 53-76.
7. Hamblin, M. R.; Governatore, M. D.; Rizvi, I.; Hasan, T. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br. J. Cancer 2000, 83 (11), 1544-1551.
8. Hamblin, M. R.; Miller, J. L.; Rizvi, I.; Ortel, B.; Maytin, E. V.; Hasan, T. Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res. 2001, 61 (19), 7155-7162.
9. Demidova, T. N.; Hamblin, M. R. Macrophage-targeted photodynamic therapy. Int. J. Immunopathol. Pharmacol. 2004, 17 (2), 117-126.
10. Hamblin, M. R.; Miller, J. L.; Ortel, B. Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 2000, 72 (4), 533-540.
11. Mantovani, A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest. 1994, 71 (1), 5-16.
12. Bingle, L.; Brown, N. J.; Lewis, C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196 (3), 254-265.
13. Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4 (1), 71-78.
14. Graves, D. T.; Valente, A. J. Monocyte chemotactic proteins from human tumor cells. Biochem. Pharmacol. 1991, 41 (3), 333-337.
15. Wu, S.; Rodabaugh, K.; Martinez-Maza, O.; Watson, J. M.; Silberstein, D. S.; Boyer, C. M.; Peters, W. P.; Weinberg, J. B.; Berek, J. S.; Bast, R. C., Jr. Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Am. J. Obstet. Gynecol. 1992, 166 (3), 997-1007.
16. Harmey, J. H.; Dimitriadis, E.; Kay, E.; Redmond, H. P.; Bouchier-Hayes, D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann. Surg. Oncol. 1998, 5 (3), 271-278.
17. Hagemann, T.; Robinson, S. C.; Schulz, M.; Trumper, L.; Balkwill, F. R.; Binder, C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25 (8), 1543-1549.
18. Elgert, K. D.; Alleva, D. G.; Mullins, D. W. Tumor-induced immune dysfunction: the macrophage connection. J. Leukocyte Biol. 1998, 64 (3), 275-290.
19. Leek, R. D.; Landers, R.; Fox, S. B.; Ng, F.; Harris, A. L.; Lewis, C. E. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br. J. Cancer 1998, 77 (12), 2246-2251.
20. Young, M. R.; Wright, M. A.; Lozano, Y.; Prechel, M. M.; Benefield, J.; Leonetti, J. P.; Collins, S. L.; Petruzzelli, G. J. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int. J. Cancer 1997, 74 (1), 69-74.
21. Lissbrant, I. F.; Stattin, P.; Wikstrom, P.; Damber, J. E.; Egevad, L.; Bergh, A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int. J. Oncol. 2000, 17 (3), 445-451.
22. Salvesen, H. B.; Akslen, L. A., Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int. J. Cancer 1999, 84 (5), 538-543.
23. Wahl, L. M.; Kleinman, H. K. Tumor-associated macrophages as targets for cancer therapy. J. Natl. Cancer Inst. 1998, 90 (21), 1583-1584.
24. Mantovani, A.; Giavazzi, R.; Polentarutti, N.; Spreafico, F.; Garattini, S. Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int. J. Cancer 1980, 25 (5), 617-620.
25. Ralph, P.; Prichard, J.; Cohn, M. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J. Immunol. 1975, 114 (2 Part 2), 898-905.
26. Rockwell, S. C.; Kallman, R. F.; Fajardo, L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 1972, 49 (3), 735-749.
27. Brattain, M. G.; Strobel-Stevens, J.; Fine, D.; Webb, M.; Sarrif, A. M. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 1980, 40, 2142-2146.
28. Gudgin Dickson, E. F.; Holmes, H.; Jori, G.; Kennedy, J. C.; Nadeau, P.; Pottier, R. H.; Rossi, F.; Russell, D. A.; Weagle, G. E. On the source of the oscillations observed during in vivo zinc phthalocyanine fluorescence pharmacokinetic measurements in mice. Photochem. Photobiol. 1995, 61 (5), 506-509.
29. Holmes, H.; Kennedy, J. C.; Pottier, R.; Rossi, R.; Weagle, G. A recipe for the preparation of a rodent food that eliminates chlorophyll-based tissue fluorescence. J. Photochem. Photobiol. B 1995, 29 (2-3).
30. Jain, R. K. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 1990, 9 (3), 253-266.
31. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995, 55 (17), 3752-3756.
32. Jain, R. K.; Baxter, L. T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988, 48 (24 Part 1), 7022-7032.
33. Park, Y. S.; Huang, L. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A. J. Drug Targeting 1993, 1 (4), 325-330.
34. Olafsen, T.; Tan, G. J.; Cheung, C. W.; Yazaki, P. J.; Park, J. M.; Shively, J. E.; Williams, L. E.; Raubitschek, A. A.; Press: M. F.; Wu, A. M. Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting. Protein Eng., Des. Sel. 2004, 17 (4), 315-323.
35. Wong, J. Y.; Chu, D. Z.; Williams, L. E.; Yamauchi, D. M.; Ikle, D. N.; Kwok, C. S.; Liu, A.; Wilczynski, S.; Colcher, D.; Yazaki, P. J.; Shively, J. E.; Wu, A. M.; Raubitschek, A. A. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. Clin. Cancer Res. 2004, 10 (15). 5014-5021.
36. Kristjansen, P. E.; Boucher, Y.; Jain, R. K. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res. 1993, 53 (20), 4764-4766.
37. Lee, I.; Boucher, Y.; Jain, R. K. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res. 1992, 52 (11), 3237-3240.
38. Roberts, M. J.; Bentley, M. D.; Harris, J. M. Chemistry for peptide and protein PEGylation. Adv. Drug Delivery Rev. 2002, 54 (4), 459-476.
39. Lackner, C.; Jukic, Z.; Tsybrovskyy, O.; Jatzko, G.; Wette, V.; Hoefler, G.; Klimpfinger, M.; Denk, H.; Zatloukal, K. Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch. 2004, 445(2), 160-167.
40. Polverini, P. J. Role of the macrophage in angiogenesis-dependent diseases. EXS 1997, 79, 11-28.
41. Gupta, S.; Mishra, A. K.; Muralidhar, K.; Jain, V. Improved targeting of photosensitizers by intratumoral administration of immunoconjugates. Technol. Cancer Res. Treat. 2004, 3 (3), 295-301.
42. Lee, C. C.; Pogue, B. W.; O'Hara, J. A.; Wilmot, C. M.; Strawbridge, R. R.; Burke, G. C.; Hoopes, P. J. Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B. Photochem. Photobiol. Sci. 2003, 2 (2), 145-150.
43. Hebeda, K. M.; Kamphorst, W.; Sterenborg, H. J.; Wolbers, J. G. Damage to tumour and brain by interstitial photodynamic therapy in the 9L rat tumour model comparing intravenous and intratumoral administration of the photosensitiser. Acta Neurochir. 1998, 140(5), 495-501.
44. Amano, T.; Prout, G. R., Jr.; Lin, C. W. Intratumor injection as a more effective means of porphyrin administration for photodynamic therapy. J. Urol. 1988, 139 (2), 392-395.